Skip to main content
Jeffrey Gelfand, MD, Neurology, San Francisco, CA

JeffreyMarcGelfandMD

Neurology • San Francisco, CA

Neuroimmunology/Multiple Sclerosis

Associate Professor of Clinical Neurology, UCSF Department of Neurology, UCSF Neuroinflammation and MS Center

Join to view full profile

Dr. Gelfand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gelfand's full profile

Already have an account?

  • Office

    505 Parnassus Ave
    San Francisco, CA 94143
    Phone+1 415-476-1489

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurology, 2007 - 2010
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2026
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing  
    Jonathan H Blum, Luke Strnad, Leonard H Calabrese, John P Betjemann, Maulik P Shah, Felicia C Chow, Mark P Gorman, John E Greenlee, Michael R Wilson, Megan B Richie, W..., JAMA

Authored Content

  • Risk of Neuroinflammatory Adverse Events with Tumor Necrosis Factor Inhibitor TreatmentMay 2020

Press Mentions

  • FSR Expands Scientific Advisory Board to Improve Research, Care
    FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024
  • Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis
    Allergy Drug Improves Function in Patients with Chronic Injury from Multiple SclerosisOctober 12th, 2017
  • Potential Prognostic Biomarker for Clinically Isolated Syndrome
    Potential Prognostic Biomarker for Clinically Isolated SyndromeJanuary 6th, 2017
  • Join now to see all

Professional Memberships

Dr. Jeffrey Gelfand, Dr. Jeffrey Gelfand, MD, Dr. J Gelfand, Dr. Jeffrey Marc Gelfand